Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)

Haruko Shima, Akiko Kada, Akihiko Tanizawa, Yuki Yuza, Akihiro Watanabe, Masaki Ito, Hideko Uryu, Katsuyoshi Koh, Chihaya Imai, Nao Yoshida, Yuhki Koga, Naoto Fujita, Akiko M. Saito, Souichi Adachi, Eiichi Ishii, Hiroyuki Shimada

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

DISCLOSURES: Kada: Bayer Yakuhin: Other: personal fees for a member of independent data monitoring committee of clinical trials, outside of the submitted work.. Imai:Juno Therapeutics: Patents & Royalties.

Original languageEnglish
Pages (from-to)25
Number of pages1
JournalBlood
Volume134
Issue number1
DOIs
Publication statusPublished - 2019 Nov 13

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)'. Together they form a unique fingerprint.

Cite this